Green tea consumption, abdominal obesity as related factors of lacunar infarction in Korean women

Journal of Nutrition, Health and Aging

Volumn 15, Issue 7, 2011, Pages 542-550

  Ko, S G ^a   Go, H ^b   Sun, S ^c   Lee, S ^c   Park, W ^d   Choi, Y ^d   Song, Y ^d   Hwang, G ^d   Kim, G ^d   Jeon, C ^d   Park, J ^d   Lee, K ^e   Cha, M ^f   Bang, O ^f   Jung, H ^g   Kim, N ^a   Shin, Y C ^a  

^a Kyung Hee University   (South Korea)

^b Semyung University   (South Korea)

^c Sangji University   (South Korea)

^d Gachon University   (South Korea)

^e Wonkwang University   (South Korea)

^f Korea Institute of Oriental Medicine (KIOM)   (South Korea)

^g Reseach Institute of Korean Medicine Policy   (South Korea)

Author keywords

Abdominal obesity; Case control study; Green tea consumption; Ischemic stroke; Lacunar infarction

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ABDOMINAL OBESITY; AGED; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CEREBROVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIETARY INTAKE; FEMALE; FOOD INTAKE; HUMAN; LACUNAR INFARCTION; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MARRIAGE; PRIORITY JOURNAL; RISK FACTOR; SMOKING; SOUTH KOREA; TEA; WAIST HIP RATIO;

EID: 80054922317     PISSN: 12797707     EISSN: 17604788     Source Type: Journal    
DOI: 10.1007/s12603-011-0054-0     Document Type: Article

References (56)

1. Mackay J, Mensah G. Atlas of Heart Disease and Stroke. Geneva: World Health organization 2004.
2. Sudlow CL, Warlow CP. Comparable studies of the incidence of stroke and its pathological types: results from an international collaboration. International Stroke Incidence Collaboration. Stroke 1997;28:491-499. (Pubitemid 27118367)
3. Jiang B, Wang WZ, Chen H, Hong Z, Yang QD, Wu SP, Du XL, Bao QJ. Incidence and trends of stroke and its subtypes in China: results from three large cities. Stroke 2006;37:63-68. (Pubitemid 43732049)
4. Kondo R, Matsumori Y, Kato N, Tsuchiya D, Kokubo Y, Sato S, Kurita K, Kato T, Kubota I, Kayama T. Trends in the incidence of stroke in Yamagata, Japan. No To Shinkei 2006;58:213-218.
5. Liang W, Huang R, Lee AH, Hu D, Binns CW. Hospitalizations for incident stroke in Shunde district, Foshan, South China. Neuroepidemiology 2008; 30:101-104. (Pubitemid 351501624)
6. Korea national Statistical office. Summary report of the Cause of Death Statistics in 2008. 2009.
7. Tanabe N., Suzuki H., Aizawa Y., Seki N. Consumption of green tea and roasted teas and the risk of stroke incidence: results from the Tokamachi-nakasato cohort study in Japan. Int J epi 2008;37:1030-1040.
8. Kuriyama S., Shimazu T., Ohmori K., Kikuchi N., Nakaya N., Nishino Y., Tsubono Y., Tsuji I. Green tea consumption and mortality due to cardiovascular diseases, cancer, and all causes in Japan. JAMA 2006;296:1255-1265. (Pubitemid 44394897)
9. Cooper R, morré DJ, morré DM. Medicinal benefits of green tea: Part I. Review of noncancer health benefits.J altern Complement med 2005;11:521-28. (Pubitemid 41001422)
10. Zaveri NT. Green tea and its polyphenolic catechins: medicinal uses in cancer and noncancer applications. Life Sci 2006;78:2073-80.
11. Curin Y, Andriantsitohaina R. Polyphenols as potential therapeutical agents against cardiovascular diseases. Pharmacol rep 2005;57(Suppl):97-107.
12. Hong JT, Ryu SR, Kim HJ, Lee JK, Lee SH, Yun YP, Lee BM, Kim PY. Brain res 2001;11-18.
13. Stensvold I, Tverdal A, Solvoll K, et al. Tea consumption. Realtionship to cholesterol, blood pressure, and coronary and total mortality. Prev med 1992;21:546-553
14. Hertog MG, Kromhout D, Aravanis C, et al. Flavonoid intake and long-term risk of coronary heart disease and cancer in the Seven Countries Study. Arch intern med 1995;155:381-386
15. Sato Y, Nakatsuka H, Watanabe T, Hisamichi S, Shimizu H, Fujisaku S, Ichinowatari Y, Ida Y, Suda S, et al. Possible contribution of green tea drinking habits to the prevention of stroke. Tohoku J exp med 1989; 157:337-43. (Pubitemid 19196202)
16. Nakachi K, Matsuyama S, Miyake S, Suganuma M, Imai K. Preventive effects of drinking green tea on cancer and cardiovascular disease: epidemiological evidence for multiple targeting prevention. Biofactors 2000; 13:49-54 (Pubitemid 32107344)
17. Iwai N, Ohshiro H, Kurozawa Y, Hosoda T, Morita H, Funakawa K, Okamoto M, Nose T. Relationship between coffee and green tea consumption and all-cause mortality in a cohort of a rural Japanese population. J epidemiol 2002;12:191-8. (Pubitemid 44235001)
18. Park HS et al. Epidemiologic Characteristics of obesity in Korean. Korena J obesity, 2003;
19. National Center for Health Statistics. Prevalence of overweight and obesity among adults: united States, 1999. Available at: http://www.cdc.gov/ nchs/products /pubs/pubd/hestats/obese/obse99table2.htm. Accessed December 6, 2001.
20. Must A, Spadano J, Coakley EH, Field AE, Colditz G, Dietz WH. The disease burden associated with overweight and obesity. Jama 1999; 282: 1523-1529. (Pubitemid 29504045)
21. National Heart, Lung, And Blood institute. The Practical Guide: identification, evaluation, And Treatment of overweight and obesity in adults. Available at: http://www.nhlbi.nih.gov/guidelines/obesity/practgde.htm accessed February 2, 2002.
22. Special report from the national institute of neurological Disorders and Stroke: classification of cerebrovascular diseases iii. Stroke 1990;21:637-676.
23. Petty GW, Brown RD JR, Whisnant JP, Sicks JD, o'Fallon WM, Wiebers DO. Ischemic stroke subtypes: a population-based study on incidence and risk factors. Stroke 1999;30: 2513-2516.
24. Petty GW, Brown RD JR, Whisnant JP, Sicks JD, o'Fallon WM, Wiebers DO. Ischemic stroke subtypes. A population-based study of functional outcome, survival, and recurrence. Stroke 2000;31:1062-1068. (Pubitemid 30253526)
25. Yumihiro Tanizaki, Yutaka Kiyohara, Isao Kato, Hiromitsu iwamoto, Keizo nakayama, Noriyasu Shinohara, Hisatomi arima, Keiichi Tanaka, Setsuro ibayashi, Masatoshi Fujishima. Incidence and risk factors for subtypes of cerebral infarction in a general population. The hisayama study. Stroke 2000;31:2616-2622.
26. Tietz NE, ed. Fundamentals of Clinical Chemistry. Philadelphia, Pa: WB Saunders Co; 1976.
27. Warnick G, Russell J, Albers JJ. Dextran sulfate-mg2+ precipitation procedures for quantification of high density-lipoprotein-cholesterol. In: Copper GR, ed. Selected methods of Clinical Chemistry. Vol 10. Washington, DC: american association for Clinical Chemistry; 1983: 91-99
28. National Cholesterol education Program. Detection, evaluation and Treatment of High Blood Cholesterol in adults (adults Treatment Panel iii). National Heart, Lung, And Blood of institute, national institute of Health. NiH Publication. 2001.
29. Walker SP, Rimm EB, Ascherio A, Kawachi I, Stampfer MJ, Willett WC. Body size and fat distribution as predictors of stroke among US men. Am J epidemiol 1996; 144: 1143-1150. (Pubitemid 26415104)
30. Ulrike Peters, Charles Poole, Lenore arab. Does tea affect cardiovascular disease? a Meta-analysis. Am J epidemiol 2001;154:495-503 (Pubitemid 32867948)
31. Sato Y, Nakatsuka H, Watanabe T, et al. Possible contribution of green tea drinking habits to the prevention of stroke. Tohoku J exp med 1989; 157:337-343 (Pubitemid 19196202)
32. Prineas RJ, Folsom AR, Kaye SA. Central adiposity and increased risk of coronary disease mortality in older women. Ann epidemiol. 1993;3:35-41. (Pubitemid 23050727)
33. Suk SH, Sacco RL, Boden-albala B, Cheun JF, Pittman JG, Elkind MS, Paik MC; northern manhattan Stroke Study. Abdominal obesity and risk of ischemic Stroke: The northern manhattan Stroke Study. Stroke 2003 34(7):1586-92. (Pubitemid 36842606)
34. Lee SY, Kim CY, Lee JJ, Jung JG, Lee SR. Effects of delayed administration of (-)-epigallocatechin gallate, a green tea polyphenol on the changes in polyamine levels and neuronal damage after transient forebrain ischemia in gerbils. Brain res Bull 2003 aug 30;61(4):399-406.
35. Laughton MJ, Evans PJ, Moroney MA, Hoult JR, Halliwell B. Inhibition of mammalian 5-lipogenase and cyclo-oxygenase by flavonoids and phenolic dietary additives. Relationship to antioxidant activity and to iron ion-reducing ability. Biochem Pharmacol 1991;42:1673-1681.
36. Geleijnse JM, Witterman JC, Launer LJ, Lamberts SW, Plos HA. Tea and coronary heart disease: protection through estrogen-like activity?. Arch intern med 2000; 160:3328-3329.
37. Lee SR, Im KJ, Suh SI, Jung JG. Protective effect of green tea polyphenol (-)-epigallocatechin gallate and other antioxidants on lipid peroxidation in gerbil brain homogenates. Phytother res 2003 mar; 17(3):206-209.
38. Rimm EB, Katan MB, Ascherio A, et al. Relation between intake of flavonoids and risk for coronary heart disease in male healthy professionals. Ann intern med 1996;125:384-389. (Pubitemid 126449708)
39. Ho CT, Chen Q, Shi H, et al. Antioxidative effects of polyphenol extract prepared from various Chinese tea. Prev med 1992;21:502-505.
40. Stromblad G, Bjorntorp P. Reduced hepatic insulin clearance in rats with dietary-induced obesity. Metabolism 1986;35:323-327. (Pubitemid 16079523)
41. Carlson LA, Boberg J, Hogsedt B. Some physiological and clinical implications of lipid mobilization from adipose tissue. In: renold AE, Cahill GF JR, eds. Adipose tissue. Sect. V of Handbook of physiology. Washington, D.C.: american Physiological Society, 1965;625-644.
42. Horton ES. The role of exercise in the treatment of hypertension in obesity. Int J obes 1981;5:Suppl 1:165-171. (Pubitemid 11090065)
43. Arcaro G, Zamboni M, Rossi L, et al. Body fat distribution predicts the degree of endothelial dysfunction in uncomplicated obesity. Int J obes 1999; 23: 936-942. (Pubitemid 29423936)
44. Davi G, Guagnano MT, Ciabattoni G, et al. Platelet activation in obese women: role of inflammation and oxidant stress. Jama 2002; 288: 2008-2014. (Pubitemid 35204691)
45. Herteg MG, Feskens EJ, Hollman PC, Katan MB, Kromhout D. Dietary antioxidant flavonoids and the risk of coronary heart disease: the Zutphen elderly Study. Lancet 1993;342:1007-1011. (Pubitemid 23314801)
46. Knekt P, Kumpulainen J, Jarvinen R, Rissanen H, Heliovaara M, Reunanen A, Hakulinen T, Aromaa A. Flavonoid intake and risk of chronic diseases. Am J Clin nutr 2002 Sep;76(3):560-8. (Pubitemid 34920833)
47. Sesso HD, Gaziano JM, Buring JE, et al. Coffee and tea intake and the risk of myocardial infarction. Am J epidemiol 1999; 149:162-167. (Pubitemid 29039519)
48. Sesso HD, Gaziano JM, Liu S, Buring JE. Flavonoid intake and the risk of cardiovascular disease in women. Am J Clin nutr 2003;77:1400-1408. (Pubitemid 39655272)
49. Knekt P, Isotupa S, Rissanen H, Heliovaara M, Jarvinen R, Hakkinen S, Aromaa A, Reunanen A. Quercetin intake and the incidence of cerebrovascular disease. Eur J Clin nutr 2000 may;54(5):415-7. (Pubitemid 30261393)
50. Willett WC, Manson JE, Stampfer MJ, Colditz GA, Rosner B, Speizer FE, Hennekens CH. Weight, weight change, and coronary heart disease in women. Jama 1995; 273: 461-465.
51. Calle EE, Thun MJ, Petrelli JM, Rodriguez C, Heath CW JR. Body-mass index and mortality in a prospective cohort of U.S. Adults. N engl J med 1999; 341:1097-1105. (Pubitemid 29466221)
52. Prineas RJ, Folsom AR, Kaye SA. Central adiposity and increased risk of coronary disease mortality in older women. Ann epidemiol 1993; 3: 35-41. (Pubitemid 23050727)
53. Rimm EB, Stampfer MJ, Giovannucci E, Aschreio A, Spiegelman D, Golditz GA, Willett WC. Body size and fat distribution as predictors of coronary heart disease among middle-aged and older US men. Am J epidemiol 1995;141:1117-1127.
54. Lapidus L, Bengtsson C, Larsson B, Pennert K, Rybo E, Sjostrom L. Distribution of adipose tissue and risk of cardiovascular disease and death: a 12 year follow up of participants in the population study of women in Gothenburg, Sweden. BMJ 1984; 289: 1257-1261. (Pubitemid 15217605)
55. Larsson B, Svardsudd K, Welin L, Wilhelmsen L, Bjorntorp P, Tibblin G. Abdominal adipose tissue distribution, obesity, and risk of cardiovascular disease and death: 13 years follow up of participants in the study of men born in 1913. BMJ 1984;288:1401-1404. (Pubitemid 14088431)
56. Hubert HB, Feinleib M, Mcnamara PM, Castelli WP. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation 1983; 67: 968-977. (Pubitemid 13080473)